MAGE-TAB Version 1.1 Comment[MetaboBank accession] MTBKS218 Study Title A lipidome atlas in MS-DIAL 4 (cultured cells study) Study Description We present Mass Spectrometry-Data Independent Analysis software version 4 (MS-DIAL 4), a comprehensive lipidome atlas with retention time, collision cross-section and tandem mass spectrometry information. We formulated mass spectral fragmentations of lipids across 117 lipid subclasses and included ion mobility tandem mass spectrometry. Using human, murine, algal and plant biological samples, we annotated and semiquantified 8,051 lipids using MS-DIAL 4 with a 1-2% estimated false discovery rate. MS-DIAL 4 helps standardize lipidomics data and discover lipid pathways. This dataset describes experiments about cultured cells. Experimental Design software variation design Experimental Factor Name cell line Experimental Factor Type cell line Person Last Name Takahashi Tsugawa Person First Name Mikiko Hiroshi Person Mid Initials Person Affiliation RIKEN Center for Sustainable Resource Science Tokyo University of Agriculture and Technology; RIKEN Center for Sustainable Resource Science; RIKEN Center for Integrative Medical Sciences Person Roles submitter submitter PubMed ID 32541957 Publication DOI Protocol Name Sample collection Extraction Chromatography Mass spectrometry Data processing Metabolite identification Protocol Type Sample collection Extraction Chromatography Mass spectrometry Data processing Metabolite identification Protocol Description 3T3-L1 cell line was seeded by 5x10^4 cells/well, cultured in 1 mL D-MEM (high glucose) with L-glutamine and phenol red (Wako, Japan) and incubated in 5% CO2 at 37 degree C in 12-well cell culture multiwell plates (Greiner bio-one). After 2 days where cells were reached to a confluency of ~70%, the medium was removed and cells were cultured in 1 mL MDI composing of 0.5 mM IBMX (Sigma-Aldrich), 1 microM dexamethasone (Sigma-Aldrich), and 10 microgram/mL insulin (Sigma-Aldrich). After 2 days, the MDI induction medium was removed and replaced with 1 mL insulin medium. After 2 days, the insulin medium was removed and replaced with fresh D-MEM. After 4 days where the medium was changed every 2 days, the medium was aspirated, and cells were washed on the plates with PBS buffer. The solution was transferred to a new glass tube, and then dried with a vacuum dryer. C2C12 cell line was seeded by 1x10^5 cells/well, cultured in 1 mL D-MEM (high glucose) with L-glutamine and phenol red (Wako, Japan) containing 10% fetal bovine serum (FBS) and Pen Strep glutamine (PSG), and incubated in 5% CO2 at 37 degree C in 24-well cell culture multiwell plates (Greiner bio-one). After over-night cultivation, the medium was aspirated, and cells were washed on the plates with PBS. After the PBS buffer was aspirated, 600 microliter of MeOH was added and the cells were detached by cell scraper. The solution was transferred to a new glass tube, and then dried with a vacuum dryer. HEK293- and HeLa cell lines were cultured in D-MEM (high-glucose) with L-glutamine (Wako) containing 10% fetal bovine serum (FBS) and Pen Strep glutamine (PSG), and incubated in 5% CO2 at 37 degree C in six-well cell culture multiwell plates (Greiner bio-one). After 1 hour cultivation, the medium was aspirated, and cells were washed on the plates with 10 mM Tris-HCl (pH 8.0) buffered saline. The lipid extraction was performed by the same mixed solvent protocol (MeOH:CHCl3:H2O, 1:2:0.2, v/v/v) as described in human plasma section. First, chloroform was added to dried cells in a tube, followed by 30-s sonication. After 60-min incubation at room temperature, methanol was added and vortexed for 10 s. After 120-min incubation, Milli-Q water was added, vortexed for 10 s, and left the tube to stand for 10 min. The cells were then centrifuged at 2000 x g for 10 min at 20 degree C. Supernatant was transferred to LC/MS vials to determine the phosphorous contents of the lipid fraction. The phosphorus content of the extracted lipids was quantified by the method of Bartlett44, and then the extracted lipids were gently dried with N2 and reconstituted with the mixed solvent of chloroform and methanol (1:2, v/v) to 0.5 mM, 0.8 mM, 1.0 mM, and 1.5 mM phosphorus for C2C12, HEK293, HeLa, and 3T3-L1, respectively, and transferred to the LC-MS vial. The LC system consisted of a Waters Acquity UPLC system. Lipids were separated on an Acquity UPLC Peptide BEH C18 column (50 x 2.1 mm; 1.7 microm) (Waters, Milford, MA, USA). The column was maintained at 45 degree C at a flow-rate of 0.3 mL/min. The mobile phases consisted of (A) 1:1:3 (v/v/v) acetonitrile:methanol:water with ammonium formate (5 mM) and 10 nM EDTA and (B) 100% isopropanol with ammonium formate (5 mM) and 10 nM EDTA. A sample volume of 0.5-3 microliter, which depended on biological samples, was used for the injection. The separation was conducted under the following gradient: 0 min 0% (B); 1 min 0% (B); 5 min 40% (B); 7.5 min 64% (B); 12 min 64% (B); 12.5 min 82.5% (B); 19 min 85% (B); 20 min 95% (B); 20.1 min 0% (B); and 25 min 0% (B). Sample temperature was maintained at 4 degree C. Mass spectrometric detection of lipids was performed on a quadrupole/time-of-flight mass spectrometer TripleTOF 5600 (SCIEX, Framingham, MA, USA). All analyses were performed at the high resolution mode in MS1 (~35,000 full width at half maximum (FWHM)) and at the high sensitivity mode (~20,000 FWHM) in MS2. Data dependent MS/MS acquisition (DDA) was used. The parameters were MS1 and MS2 mass ranges, m/z 70-1250; MS1 accumulation time, 250 ms; MS2 accumulation time, 100 ms; collision energy, +40/-42 eV; collision energy spread, 15 eV; cycle time, 1300 ms; curtain gas, 30; ion source gas 1, 40(+)/50(-); ion source gas 2, 80(+)/50(-); temperature, 250 degree C(+)/300 degree C(-); ion spray voltage floating, +5.5/-4.5 kV; declustering potential, 80 V. The other DDA parameters were dependent product ion scan number, 16; intensity threshold, 100 cps; exclusion time of precursor ion, 0s; mass tolerance, 20 ppm; ignore peaks, within m/z 200; and dynamic background subtraction, True. The mass calibration was automatically performed using an APCI positive/negative calibration solution via a calibration delivery system (CDS). use MS-DIAL ver.4.0 (For parameters used: Supplementary Table S3e at https://doi.org/10.1038/s41587-020-0531-2). use MS-DIAL ver.4.0 Protocol Parameters Post extraction;Derivatization Chromatography instrument;Autosampler model;Column model;Column type;Guard column Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Protocol Hardware Protocol Software MS-DIAL ver.4.0 MS-DIAL ver.4.0 Public Release Date 2023-06-14 Term Source Name Term Source File Term Source Version SDRF File MTBKS218.sdrf.txt Comment[Study type] lipid profiling Comment[Experiment type] liquid chromatography-mass spectrometry tandem mass spectrometry time-of-flight mass spectrometry quadrupole mass spectrometer data-dependent acquisition Comment[Submission type] LC-MS Comment[BioProject] PRJDB15006 Comment[Related study] Comment[Contributor] Kazutaka Ikeda(Department of Applied Genomics, Kazusa DNA Research Institute; RIKEN Center for Integrative Medical Sciences), Masanori Arita(National Institute of Genetics; RIKEN Center for Sustainable Resource Science), Makoto Arita(RIKEN Center for Integrative Medical Sciences; Graduate School of Pharmaceutical Sciences, Keio University; Graduate School of Medical Life Science, Yokohama City University) Comment[Submission Date] 2022-12-28 Comment[Last Update Date] 2023-06-14